200 related articles for article (PubMed ID: 38056896)
21. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
[TBL] [Abstract][Full Text] [Related]
22. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
[TBL] [Abstract][Full Text] [Related]
23. Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8
Shimizu K; Ueda S; Kawamura M; Aoshima H; Satoh M; Nakabayashi J; Fujii SI
J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37400134
[TBL] [Abstract][Full Text] [Related]
24. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
[TBL] [Abstract][Full Text] [Related]
25. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells.
Münz C; Dao T; Ferlazzo G; de Cos MA; Goodman K; Young JW
Blood; 2005 Jan; 105(1):266-73. PubMed ID: 15331446
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells.
Seebauer CT; Brunner S; Glockzin G; Piso P; Ruemmele P; Schlitt HJ; Geissler EK; Fichtner-Feigl S; Kesselring R
Oncoimmunology; 2016; 5(12):e1242543. PubMed ID: 28439450
[No Abstract] [Full Text] [Related]
27. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
[TBL] [Abstract][Full Text] [Related]
28. Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist.
Knudson KM; Hicks KC; Ozawa Y; Schlom J; Gameiro SR
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303618
[TBL] [Abstract][Full Text] [Related]
29. Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.
Milush JM; Long BR; Snyder-Cappione JE; Cappione AJ; York VA; Ndhlovu LC; Lanier LL; Michaëlsson J; Nixon DF
Blood; 2009 Nov; 114(23):4823-31. PubMed ID: 19805616
[TBL] [Abstract][Full Text] [Related]
30. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
Wehner R; Löbel B; Bornhäuser M; Schäkel K; Cartellieri M; Bachmann M; Rieber EP; Schmitz M
Int J Cancer; 2009 Jan; 124(2):358-66. PubMed ID: 18942710
[TBL] [Abstract][Full Text] [Related]
32. Increased production of IFN-γ by natural killer cells triggered with bone marrow-derived dendritic cells cultured in the presence of retinoic acid.
Chau J; Moza D; Hossain N; Lee JK; Bienenstock J; Karimi K
Eur J Pharmacol; 2013 Sep; 715(1-3):321-7. PubMed ID: 23701916
[TBL] [Abstract][Full Text] [Related]
33. IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment.
Wong JL; Berk E; Edwards RP; Kalinski P
Cancer Res; 2013 Aug; 73(15):4653-62. PubMed ID: 23761327
[TBL] [Abstract][Full Text] [Related]
34. CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma.
Cho MM; Song L; Quamine AE; Szewc F; Shi L; Erbe AK; Ebben JD; Turicek DP; Kline JM; Burpee DM; Lafeber EO; Phillips MF; Ceas AS; Capitini CM
bioRxiv; 2024 Jun; ():. PubMed ID: 37333207
[TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.
Dauer M; Pohl K; Obermaier B; Meskendahl T; Röbe J; Schnurr M; Endres S; Eigler A
Immunology; 2003 Sep; 110(1):38-47. PubMed ID: 12941139
[TBL] [Abstract][Full Text] [Related]
36. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
[TBL] [Abstract][Full Text] [Related]
37. Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer.
Kennedy PR; Felices M; Miller JS
Stem Cell Res Ther; 2022 Apr; 13(1):165. PubMed ID: 35414042
[TBL] [Abstract][Full Text] [Related]
38. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM
Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146
[TBL] [Abstract][Full Text] [Related]
39. Monocytes play an IL-12-dependent crucial role in driving cord blood NK cells to produce IFN-g in response to Trypanosoma cruzi.
Guilmot A; Bosse J; Carlier Y; Truyens C
PLoS Negl Trop Dis; 2013; 7(6):e2291. PubMed ID: 23819002
[TBL] [Abstract][Full Text] [Related]
40. Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.
Barkholt L; Alici E; Conrad R; Sutlu T; Gilljam M; Stellan B; Christensson B; Guven H; Björkström NK; Söderdahl G; Cederlund K; Kimby E; Aschan J; Ringdén O; Ljunggren HG; Dilber MS
Immunotherapy; 2009 Sep; 1(5):753-64. PubMed ID: 20636021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]